Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Philips Medical Launches New Stethoscopes
November 19, 2001
- Japanese Global Strategy Update (7)
November 19, 2001
- Regulations Related to Medical Devices to Be Reviewed
November 19, 2001
- Takeda: 7.7% Sales Increase Attributable to Int'l Strategic Products
November 19, 2001
- Terumo: Sales Up 7.3%, Profits Down
November 19, 2001
- Santen: Independent Marketing in US Pushes Up Sales
November 19, 2001
- Iressa Effective against NSCLC: PII Results in Int'l Joint Trial
November 19, 2001
- Makers Rush to Apply for Anthrax as Additional Indication
November 19, 2001
- Takeda to Set Up Facility for Gene, Protein Function Analysis
November 19, 2001
- Mitsubishi Research Institute Launches Coding Software Based on Ethical GL
November 19, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
November 19, 2001
- BUSINESS NEWS IN BRIEF
November 19, 2001
- Greencross-coa: Sales Up 21% to \23.4 Bil.
November 19, 2001
- OBITUARY
November 19, 2001
- DIAGNOSTIC NEWS IN BRIEF
November 19, 2001
- Industry Fights Price Cuts of Original Products: Chuikyo
November 19, 2001
- Cawachi: Half-year Ordinary Profits Remarkably Up 17.8%
November 19, 2001
- 3 NCEs Including Remicade Recommended to Be Approved
November 19, 2001
- Consumers Take Health-Oriented Foods for Better Nutritional Balance: JMARI Survey
November 19, 2001
- BULLETIN
November 19, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…